NOVOSTEO

Novosteo, Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients' morbidity, mortality and loss of mobility and productivity associated with bone fractures, bone metastasis and infection. Scientific co-founders Stewart Low and Philip Low of Purdue University have created a proprietary chemistry approach to bone targeting and have discovered novel biologics that accelerate bone regeneration by delivering anabolic agents preferentially to fracture surfaces.

#SimilarOrganizations #People #Financial #Website #More

NOVOSTEO

Social Links:

Linkedin

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2017-01-01

Address:

Indiana, Pennsylvania, United States

Country:

United States

Website Url:

http://www.novosteo.com

Total Employee:

1+

Status:

Active

Contact:

765-761-3912

Total Funding:

7.95 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail Amazon Route 53 Amazon S3 CDN Lorem Ipsum

Similar Organizations

1200-pharma-logo

1200 Pharma

1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.

apic-bio-logo

Apic Bio

Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.

braeburn-logo

Braeburn

Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

Current Advisors List

isaac-barchas_image

Isaac Barchas Board Member @ Novosteo
Board_member
2019-02-01

Current Employees Featured

dan-hasler_image

Dan Hasler
Dan Hasler CEO @ Novosteo
CEO

philip-low_image

Philip Low
Philip Low Co-founder & Director @ Novosteo
Co-founder & Director
2017-05-01

stewart-low_image

Stewart Low
Stewart Low VP of Research and Development and Co-Founder @ Novosteo
VP of Research and Development and Co-Founder
2017-03-01

brendan-hannah_image

Brendan Hannah
Brendan Hannah Chief Operating Officer @ Novosteo
Chief Operating Officer
2021-11-01

scott-salka_image

Scott Salka
Scott Salka Executive Chairman @ Novosteo
Executive Chairman
2019-08-01

Founder

philip-low_image

Philip Low

stewart-low_image

Stewart Low

Investors List

kairos-venture-investments-llc_image

Kairos Ventures

Kairos Ventures investment in Series A - Novosteo

biocrossroads_image

BioCrossroads

BioCrossroads investment in Series A - Novosteo

purdue-research-foundation_image

Purdue Research Foundation

Purdue Research Foundation investment in Series A - Novosteo

elevate-ventures_image

Elevate Ventures

Elevate Ventures investment in Series A - Novosteo

research-bridge-partners_image

Research Bridge Partners

Research Bridge Partners investment in Seed Round - Novosteo

purdue-research-foundation_image

Purdue Research Foundation

Purdue Research Foundation investment in Pre Seed Round - Novosteo

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Novosteo

Official Site Inspections

http://www.novosteo.com

Host Informations
Whois Informations

Loading ...

More informations about "Novosteo" on Search Engine